Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

VYNE Therapeutics (VYNE) Non-cash Items (2016 - 2019)

VYNE Therapeutics' Non-cash Items history spans 4 years, with the latest figure at $2.9 million for Q4 2019.

  • For Q4 2019, Non-cash Items rose 14.27% year-over-year to $2.9 million; the TTM value through Dec 2019 reached $2.9 million, up 14.27%, while the annual FY2019 figure was $2.9 million, 14.27% up from the prior year.
  • Non-cash Items reached $2.9 million in Q4 2019 per VYNE's latest filing, up from $2.8 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $24.0 million in Q4 2017 to a low of $2.5 million in Q4 2018.
  • Average Non-cash Items over 4 years is $8.7 million, with a median of $5.7 million recorded in 2019.
  • Peak YoY movement for Non-cash Items: surged 531.62% in 2017, then tumbled 89.56% in 2018.
  • A 4-year view of Non-cash Items shows it stood at $3.8 million in 2016, then soared by 531.62% to $24.0 million in 2017, then crashed by 89.56% to $2.5 million in 2018, then rose by 14.27% to $2.9 million in 2019.
  • Per Business Quant, the three most recent readings for VYNE's Non-cash Items are $2.9 million (Q4 2019), $2.8 million (Q3 2019), and $5.7 million (Q2 2019).